Center for Speech & Language Recovery
Clinical Trials

You are here

Using tDCS in Speech-Based Stroke Rehabilitation

CLINICAL TRIAL: 
In-Progress / Currently Recruiting Participants
October 1, 2019
Person using tDSC for speech rehab

Qualifying participants who have had a stroke and have apraxia of speech will receive up to 24 speech therapy sessions over a 4 to 6 month period, at no charge. 

Transcranial direct current stimulation (tDCS), a form of non-invasive brain stimulation, will also be used during a portion of speech therapy. tDCS is considered a non-risk device by the FDA, and is safe to use. Low doses of electrical current will be administered through the scalp over areas that may assist with speech recovery. 

Eligibility

Inclusion Criteria: 

For patients with stroke:

  • Have experienced a stroke and have apraxia of speech

Inquire About Clinical Trials

If you would like more information regarding the clinical trials conducted at Burke Neurological Institute or to express your interest in participating, please fill out and submit this form.

Your Information

Name & Address

A Few Questions

Clinical Trials

(Check all that are of interest)
(Title of clinical trial currently viewing)

Your Message

Contact

Susan Wortman-Jutt, M.S., CCC-SLP

Study Locations

Burke Neurological Institute
785 Mamaroneck Avenue
White Plains, NY 10605

Associated

Causes